BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 536 filers reported holding BIO-TECHNE CORP in Q1 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,325,619 | -17.4% | 63,547 | -1.0% | 0.02% | -19.0% |
| Q2 2023 | $5,239,863 | +5.3% | 64,190 | -4.3% | 0.02% | -4.5% |
| Q1 2023 | $4,975,272 | -10.9% | 67,061 | -0.5% | 0.02% | -21.4% |
| Q4 2022 | $5,583,958 | +29.3% | 67,374 | +343.0% | 0.03% | +12.0% |
| Q3 2022 | $4,319,000 | -2.5% | 15,207 | +19.0% | 0.02% | -13.8% |
| Q2 2022 | $4,430,000 | -15.5% | 12,781 | +5.6% | 0.03% | -14.7% |
| Q1 2022 | $5,241,000 | -8.8% | 12,103 | +9.0% | 0.03% | -12.8% |
| Q4 2021 | $5,745,000 | +5.0% | 11,105 | -1.6% | 0.04% | -13.3% |
| Q3 2021 | $5,470,000 | +4.3% | 11,288 | -3.1% | 0.04% | -8.2% |
| Q2 2021 | $5,246,000 | +12.5% | 11,652 | -4.6% | 0.05% | -2.0% |
| Q1 2021 | $4,663,000 | +21.7% | 12,208 | +1.1% | 0.05% | -2.0% |
| Q4 2020 | $3,833,000 | +29.5% | 12,070 | +1.4% | 0.05% | +4.1% |
| Q3 2020 | $2,959,000 | +2.9% | 11,899 | +10.0% | 0.05% | +4.3% |
| Q2 2020 | $2,877,000 | +38.9% | 10,816 | -3.1% | 0.05% | +2.2% |
| Q1 2020 | $2,071,000 | -14.2% | 11,167 | +1.6% | 0.05% | +21.1% |
| Q4 2019 | $2,413,000 | +9.7% | 10,996 | -2.2% | 0.04% | -50.6% |
| Q3 2019 | $2,200,000 | -5.1% | 11,242 | +1.1% | 0.08% | -10.5% |
| Q2 2019 | $2,319,000 | +4.9% | 11,125 | -0.0% | 0.09% | -4.4% |
| Q1 2019 | $2,210,000 | +37.9% | 11,130 | +0.5% | 0.09% | +4.7% |
| Q4 2018 | $1,603,000 | -29.2% | 11,074 | -0.2% | 0.09% | -14.9% |
| Q3 2018 | $2,265,000 | +37.1% | 11,098 | -0.6% | 0.10% | +9.8% |
| Q2 2018 | $1,652,000 | -2.7% | 11,168 | -4.6% | 0.09% | -12.4% |
| Q1 2018 | $1,697,000 | +12.7% | 11,710 | +0.7% | 0.10% | +15.4% |
| Q4 2017 | $1,506,000 | -0.1% | 11,624 | +5.7% | 0.09% | +42.2% |
| Q3 2017 | $1,507,000 | – | 11,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ownership Capital B.V. | 972,263 | $308,742,000 | 4.35% |
| Sandhill Capital Partners LLC | 138,864 | $44,096,000 | 4.03% |
| STONE RUN CAPITAL, LLC | 27,350 | $8,685,000 | 3.45% |
| DF DENT & CO INC | 925,823 | $293,995,000 | 3.42% |
| Brown Capital Management | 1,498,233 | $475,764,000 | 3.29% |
| MAIRS & POWER INC | 848,081 | $269,308,000 | 2.99% |
| Summit Creek Advisors LLC | 64,179 | $20,380,000 | 2.62% |
| GENEVA CAPITAL MANAGEMENT LLC | 402,958 | $127,959,000 | 2.17% |
| Aristotle Atlantic Partners, LLC | 86,993 | $27,625,000 | 2.13% |
| CROWN ADVISORS MANAGEMENT, INC. | 8,000 | $2,540,000 | 1.82% |